Tanaka K - Search Results

1

Decreased vancomycin clearance in patients with congestive heart failure.

Shimamoto Y, Fukuda T, Tominari S, Fukumoto K, Ueno K, Dong M, Tanaka K, Shirasaka T, Komori K. Shimamoto Y, et al. Among authors: tanaka k. Eur J Clin Pharmacol. 2013 Mar;69(3):449-57. doi: 10.1007/s00228-012-1340-4. Epub 2012 Jul 12. Eur J Clin Pharmacol. 2013. PMID: 22791272

2

Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.

Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D. Shimamoto Y, et al. Among authors: tanaka k. Intensive Care Med. 2013 Jul;39(7):1247-52. doi: 10.1007/s00134-013-2909-9. Epub 2013 Apr 20. Intensive Care Med. 2013. PMID: 23604132

3

Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients.

Yonezawa E, Matsumoto K, Ueno K, Tachibana M, Hashimoto H, Komamura K, Kamakura S, Miyatake K, Tanaka K. Yonezawa E, et al. Among authors: tanaka k. J Clin Pharmacol. 2002 Mar;42(3):342-6. doi: 10.1177/00912700222011265. J Clin Pharmacol. 2002. PMID: 11865972

4

Impairment of ciprofloxacin absorption by calcium polycarbophil.

Kato R, Ueno K, Imano H, Kawai M, Kuwahara S, Tsuchishita Y, Yonezawa E, Tanaka K. Kato R, et al. Among authors: tanaka k. J Clin Pharmacol. 2002 Jul;42(7):806-11. doi: 10.1177/009127002401102641. J Clin Pharmacol. 2002. PMID: 12092748 Clinical Trial.

5

Impairment of mycophenolate mofetil absorption by calcium polycarbophil.

Kato R, Ooi K, Ikura-Mori M, Tsuchishita Y, Hashimoto H, Yoshimura H, Uenishi K, Kawai M, Tanaka K, Ueno K. Kato R, et al. Among authors: tanaka k. J Clin Pharmacol. 2002 Nov;42(11):1275-80. doi: 10.1177/009127002762491389. J Clin Pharmacol. 2002. PMID: 12412828 Clinical Trial.

6

Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia.

Fukumoto K, Kobayashi T, Tachibana K, Kato R, Tanaka K, Komamura K, Kamakura S, Kitakaze M, Ueno K. Fukumoto K, et al. Among authors: tanaka k. Drug Metab Pharmacokinet. 2006 Dec;21(6):501-5. doi: 10.2133/dmpk.21.501. Drug Metab Pharmacokinet. 2006. PMID: 17220566 Free article. Clinical Trial.

7

The effect of bucolome, a CYP2C9 inhibitor, on the pharmacokinetics of losartan.

Kobayashi M, Takagi M, Fukumoto K, Kato R, Tanaka K, Ueno K. Kobayashi M, et al. Among authors: tanaka k. Drug Metab Pharmacokinet. 2008;23(2):115-9. doi: 10.2133/dmpk.23.115. Drug Metab Pharmacokinet. 2008. PMID: 18445991 Free article. Clinical Trial.

8

Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity.

Moriguchi J, Kato R, Nakagawa M, Hirotani Y, Ijiri Y, Tanaka K. Moriguchi J, et al. Among authors: tanaka k. Eur J Pharmacol. 2007 Jun 22;565(1-3):220-4. doi: 10.1016/j.ejphar.2007.02.058. Epub 2007 Mar 12. Eur J Pharmacol. 2007. PMID: 17399699

9

Effects of lipopolysaccharide on P-glycoprotein expression and activity in the liver and kidneys.

Kato R, Moriguchi J, Irie T, Nakagawa M, Kusukawa Y, Matsumura H, Ijiri Y, Tanaka K. Kato R, et al. Among authors: tanaka k. Eur J Pharmacol. 2010 Jun 25;636(1-3):155-8. doi: 10.1016/j.ejphar.2010.03.024. Epub 2010 Mar 29. Eur J Pharmacol. 2010. PMID: 20353768

10

Is cyclosporine A transport inhibited by pravastatin via multidrug resistant protein 2?

Kato R, Nishide M, Kozu C, Iwamoto A, Urashima K, Suzuki K, Ijiri Y, Hayashi T, Tanaka K. Kato R, et al. Among authors: tanaka k. Eur J Clin Pharmacol. 2010 Feb;66(2):153-8. doi: 10.1007/s00228-009-0740-6. Epub 2009 Oct 13. Eur J Clin Pharmacol. 2010. PMID: 19823813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,795 results

Search Page

Filters